Furthermore, CD30 is a target for some subtypes of peripheral T cell lymphoma, especially anaplastic large-cell lymphoma, where it is highly expressed. This evidence concerns the gene TNFRSF8 and peripheral T-cell lymphoma, not otherwise specified.